The irradiation discount is the price differential between a gemstone whose colour is the result of irradiation treatment and a comparable stone whose colour is natural and untreated. The discount is one of the largest in the gem trade and reflects market preference for natural origin, the abundance of low-cost starting material for treatment, and the established detection capability of major laboratories.

Magnitude of the discount

The discount varies sharply by species. For blue topaz, which is overwhelmingly an irradiated product, the natural counterpart is so rare that documented natural blue topaz with a laboratory report can sell at fifty to a hundred times the price of treated material in comparable size and clarity. For coloured diamonds, where irradiated stones constitute a significant share of the fancy-yellow, fancy-green, and fancy-pink markets, the discount on treated material is typically eighty to ninety-five per cent off the natural price. A natural fancy vivid yellow at twenty thousand dollars per carat may have a treated counterpart at one to two thousand per carat with comparable appearance.

For irradiated yellow sapphire, kunzite, and certain tourmalines, where treatment is less universally applied and where natural stones of fine colour exist in commercial quantities, the discount runs at thirty to seventy per cent. For smoky quartz, which is so abundant in both natural and treated forms that the trade rarely distinguishes them, no significant discount applies in routine commerce, although top-grade morion or cairngorm with documented natural origin can still command a modest premium over treated material.

Drivers of the discount

Three factors set the size of the discount. The first is the abundance and unit cost of starting material. Colourless topaz, colourless or off-colour diamond, and pale kunzite are all relatively cheap and plentiful, so the supply curve of treated gems is essentially flat. The second is the cost and ease of treatment. Cobalt-60 gamma facilities, linear accelerators, and reactor irradiation services exist on commercial terms, with batch costs at a few dollars to tens of dollars per carat depending on the route. The third is the market preference for natural origin, which has been formalised over the past two decades through laboratory reports and pricing guidance.

Dynamics over time

The irradiation discount has tended to widen rather than narrow, as the trade and consumer awareness of treatment have grown and as laboratory detection has improved. Twenty years ago, irradiated coloured diamonds were sometimes sold without explicit disclosure into the lower-end market, and the price gap between treated and natural was less reliably observed. The development of standardised reports from GIA, IGI, and the Swiss laboratories and the rise of online price guides such as the Rapaport diamond price list have made the differential more transparent and more enforced.

Practical guidance

Trade buyers and investors approach irradiated stones as legitimate but distinct asset classes from natural-colour material. A treated fancy yellow diamond is a perfectly reasonable retail product at its treated price, and the market for it is active. As an investment, however, the treated stone tracks treated-market dynamics rather than the long-term appreciation patterns of natural fancy colour. The same logic applies to blue topaz, kunzite, and other irradiated coloured stones: priced correctly and disclosed honestly, they are useful trade goods, but their resale and appreciation profile differs from the natural counterpart.